[Paradoxical cutaneous manifestations during anti-TNF-alpha therapy].
Viguier
M
M
Service de dermatologie, hôpital Saint-Louis, université Paris VII, Paris, France.
Richette
P
P
Bachelez
H
H
Wendling
D
D
Aubin
F
F
D003875:Drug Eruptions / Q000209:etiology*; D016460:Granuloma Annulare / Q000139:chemically induced; D006801:Humans; D011565:Psoriasis / Q000139:chemically induced; D012218:Rheumatoid Nodule / Q000139:chemically induced; D012507:Sarcoidosis / Q000139:chemically induced; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000139:chemically induced
D014409:Tumor Necrosis Factor-alpha